Spartha Medical’s participation in the 5th « Healthcare & Life Science & Entrepreneurship Workshop Spartha Medical participated on September 3rd and 4th at the 5th « Healthcare & Life Science & Entrepreneurship Workshop » in the University of Pisa in Italy. The main themes … Read More

SPARTHA MEDICAL: At war against microbes and viruses Here is a new article on SPARTHA MEDICAL in Point éco Alsace by the CCI. This article traces the evolution of the company’s activities. The start-up is developing antimicrobial coatings to fight infections … Read More

Bourse French Tech Emergence We are happy to announce that we have been given Bourse French Tech Emergence by Bpifrance for our work on the development of biocompatible antiviral sprays. We would like to thank all our partners particularly SEMIA … Read More

Anti-SARS-CoV-2 coating project to protect hospital teams Explanation of our new anti SARS-CoV-2 project by our CSO.  SPARTHA Medical is working on the development of antiviral coatings, applicable on the surface of medical devices, various surfaces and even eventually on … Read More

Polyarginine Decorated Polydopamine Nanoparticles With Antimicrobial Properties for Functionalization of Hydrogels A new research article from Spartha in collaboration with INSERM U1121 and University of Strasbourg. The article describes the delivery of our technology in nanoparticle format, which enables its … Read More

Polyanionic Hydrogels as Reservoirs for Polycationic Antibiotic Substitutes Providing Prolonged Antibacterial Activity A recent article on one of our hydrogel based formulations and their use in combination with woundcare products against multiple infections. In collaboration with INSERM UMR 1121. Implantation … Read More

SPARTHA MEDICAL develops coatings to eliminate bacteria and viruses  SPARTHA MEDICAL has developed an anti-SARS-CoV-2 spray thanks to its expertise in the development of coatings. This spray, mainly intended for the general public, eliminates microbes (viruses and bacteria) on nearly … Read More

Personalization of medical device interfaces: decreasing implant-related complications by modular coatings and immunoprofiling A new editorial in Future Science Open Access Journal from our CEO and CSO. Personalized medicine currently plays a major role in reducing complications following surgery involving … Read More

SPARTHA MEDICAL obtains funding from the French National Research Agency (ANR) for the development of its anti-COVID-19 spray SPARTHA MEDICAL’s project is to develop a spray capable of immobilising and destroying COVID-19 and many other viruses on all kinds of … Read More

SPARTHA MEDICAL to conquer America as part of the Deeptech North America program SPARTHA MEDICAL has been selected to participate in the NETVA programme run by the Ministry of Europe and Foreign Affairs. The objective is to explore the market … Read More

SPARTHA MEDICAL is developing an anti-COVID-19 spray The start-up SPARTHA MEDICAL has received funding from the French National Research Agency (ANR) for the development of a spray capable of removing COVID-19 from a large number of surfaces.  The anti-viral solution … Read More

SPARTHA MEDICAL develops a new solution against COVID-19: a nasal and oral spray The start-up is developing an anti-viral coating. Its application would initially be hospital-based, but the technology can also be developed for the general public. It comes in … Read More

SPARTHA MEDICAL is one of the 14 Laureates of NETVA  2020 North America DeepTech programme organised by French Ministry of Foreign Affairs.As a part of the programme SPARTHA Medical will have a 1 week immersion in Los Angeles with the help … Read More

Un spray antiviral efficace contre le covid-19 ? C’est ce que développe actuellement Spartha Medical, biotech strasbourgeoise soutenue par l’ANR, Agence nationale de la recherche. Read More

En un coup de spray, défendre sa bouche et ses narines du coronavirus… Avec quelques autres pulvérisations, protéger le matériel d’une chambre d’hôpital… Il faudra attendre plusieurs mois pour savoir si les recherches de Spartha Medical permettront cette révolution. L’Agence … Read More

. … Read More

TERMINANION: SPARTHA Medical was granted a collaborative project by ANR(French National research agency). SPARTHA Medical with 2 INSERM units(INSERM 110 and 1121) will develop sprayable anti-viral coatings agains SARS-COV-2. Read more

Click the link … Read More

local biotechnology cluster with strong international links … Read More